Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
Deprecated: Implicit conversion from float 229.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 BMC+Hematol 2015 ; 15 (ä): ä Nephropedia Template TP
gab.com Text
Twit Text FOAVip
Twit Text #
English Wikipedia
Gum Arabic as fetal hemoglobin inducing agent in sickle cell anemia; in vivo study #MMPMID26719803
Kaddam L; FdleAlmula I; Eisawi OA; Abdelrazig HA; Elnimeiri M; Lang F; Saeed AM
BMC Hematol 2015[]; 15 (ä): ä PMID26719803show ga
Background: High levels of fetal haemoglobin (HbF) decrease sickle cell anaemia (SCA) severity and leads to improved survival. According to in vivo and in vitro studies, butyrate increases HbF production. Its utilization in clinical practice is hampered, however, by its short half-life. Serum butyrate concentrations could be enhanced by colonic bacterial fermentation of Gum Arabic (GA), edible, dried, gummy exudates from Acacia Senegal tree. We hypothesized that regular intake of GA increases serum butyrate levels, thus inducing HbF production and ameliorating symptoms of sickle cell anemia. Methods: Fourty seven patients (5?42 years) carrying hemoglobin SS were recruited from April 2014 to January 2015. Patients received 30 g/day GA for 12 weeks. HbF, blood count and erythropoietin level were measured. The main outcome of interest was the level of HbF after 12 weeks. The secondary outcomes were improvement in clinical and laboratory results. The study was ethically approved by Alneelain University IRB. Results: The study revealed significant increase in HbF level P.V0.000 [95 % CI, 0.43?1.02], MCV P.V:000 [95 % CI, 2.312?6.058] and Hematocrit level P.V:0.026 [95 % CI, 0.124?1.902]. No significant difference was encountered in platelets count P.V: 0.346 [95 % CI,?25.76?71.94], and WBCs count P.V:0.194 [95 % CI,?8.035?1.68]. Thirty seven percent of patients experienced minor side effects which resolved within a week. Conclusion: These findings reveal a novel effect of GA, which may be used to foster fetal hemoglobin production. Trial registration: ClinicalTrials.gov Identifier: NCT02467257. Registered 3rd June 2015. Electronic supplementary material: The online version of this article (doi:10.1186/s12878-015-0040-6) contains supplementary material, which is available to authorized users.